Tumour Lysis Syndrome Occurring in a Patient with Metastatic Gastrointestinal Stromal Tumour Treated with Glivec (Imatinib Mesylate, Gleevec, STI571)

Tumour lysis syndrome (TLS) is a rare side effect of chemotherapy for solid tumours. It describes the metabolic derangements following rapid and extensive tumour cell death following a good response to chemotherapy. Symptoms are those of metabolic derangement and renal failure. Treatment involves re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Pinder, Elizabeth M., Atwal, Gurprit S. S., Ayantunde, Abraham A., Khan, Sarah, Sokal, Mike, McCulloch, Tom, Parsons, Simon L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2007
Soggetti:
Case Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2225466/
https://ncbi.nlm.nih.gov/pubmed/18274611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2007/82012
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi